Recurrent community-acquired Clostridium(Clostridioides)difficile infection in Serbianchildren

Abstract

Information on recurrent Clostridium difficile infections (rCDI) in children is rare and limited, especially community acquired (CA-CDI).This study was designed to identify risk factors for rCA-CDI in Serbian pediatric population. The study group included 71 children (aged from 1 to 14 years) with a first episode of CDI. Data were collected from 56 (78.87%) children with only one episode of CA-CDI and from 15 (21.13%) children with rCA-CDI were mutually compared. The following parameters were found to be statistically significantly more frequent in the children with rCA-CDI group (p < 0.05); leukemia as underlying disease, treatment with immunosuppressive and-or cytostatic drugs, and treatment with antibiotics. Similarly, previously visits to outpatient facilities, daycare hospitals and hospitals were also associated with rCDI. Analysis of clinical symptoms and laboratory parameters, revealed a statistically significant association of the severity of the first episode of CDI (determined by an increase in body temperature, higher maximum WBC and higher CRP) with development of a rCDI. Ribotype (RT) 027 was more common in children with rCA-CDI (66.7%, p = 0.006). During the seven-year research period, we found a rate of rCA-CDI rate in children of 21.13%. Our study identified several parameters statistically significantly more frequently in children with rCA-CDI. The obtained results will serve as a basis for future larger studies, but new prospective, studies are necessary to build a prediction model of rCDI in children that can be used to guide the treatment to prevent rCDI.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Khanna S, Baddour LM, Huskins WC, Kammer PP, Faubion WA, Zinsmeister AR et al (2013) The epidemiology of Clostridium difficile infection in children: a population – based study. Clin Infect Dis 56(10):1401–1406

    CAS  Article  Google Scholar 

  2. 2.

    Khanna S, Pardi D, Aronson S, Kammer P, Orenstein R, Sauver J et al (2012) The epidemiology of community-acquired Clostridium difficile infection: a population – based study. Am J Gastroenterol 107:89–95

    Article  Google Scholar 

  3. 3.

    Pant C, Deshpande D, Altaf MA, Minocha A, Sferra T (2013) Clostridium difficile infection in children: a comprehensive review. Curr Med Res Opin 29(8):967–984

    Article  Google Scholar 

  4. 4.

    Sandora TJ, Fung M, Flaherty K et al (2011) Epidemiology and risk factors for Clostridiumdifficile infetions in children. Pediatr Infect Dis J 30:580–584

    Article  Google Scholar 

  5. 5.

    Abou Chakra CN, Pepin J, Sirard S, Valiquette L (2014) Risk factors for recurrence, complications and mortality in Clostridium difficile infetion: a systematic review. PLoS One 9(6):e98400

    Article  Google Scholar 

  6. 6.

    Schwab E, Wilkes J, Korgenski K, Herah A, Pavia A, Stevens V (2016) Risk factors for recurrent Clostridium difficile infection in pediatric inpatients. Hosp Pediatr 6:339–344

    Article  Google Scholar 

  7. 7.

    Tschudin-Sutter S, Tamma P, Milstone A, Perl T (2014) Predictors of first recurrence of Clostridium difficile infection in children. Pediatr Infect Dis J 33:414–416

    Article  Google Scholar 

  8. 8.

    Garey KW, Sethi S, Yadav Y, DuPont HL (2008) Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect 70:298–304

    CAS  Article  Google Scholar 

  9. 9.

    Rao K, Higgins P, Young V (2018) An observational cohort study of Clostridium difficile ribotype 027 and recurrent infection. mSphere 3:\

    Article  Google Scholar 

  10. 10.

    Kociolek L, Palac H, Patel S, Shulman S, Gerding D (2015) Risk factors for recurrent Clostridium difficile infection in children: a nested case-control study. J Pediatr 167:384–389

    Article  Google Scholar 

  11. 11.

    Nicholson M, Thomsen I, Slaughter J, Creech CB, Edwards K (2015) Novel risk factors for recurrent Clostridium difficile infection in children. J Pediatr Gastroenterol Nutr 60:18–22

    Article  Google Scholar 

  12. 12.

    Nicholson M, Crews J, Starke J, Jiang Z, DuPont H, Edwards K (2017) Recurrent Clostridium difficile infection in children: patient risk factors and markers of intestinal inflammation. Pediatr Infect Dis J 36:379–383

    Article  Google Scholar 

  13. 13.

    Borali E, Ortisi G, Moretti C, Stacul E, Liprere R, Gesu G, Giacomo C (2015) Community-acquired Clostridium difficile infection in children: a retrospective study. Dig Liver Dis 47:842–846

    Article  Google Scholar 

  14. 14.

    Predrag S, Branislava K, Nikola S, Niko R, Zorica SR, Stanković-Đorđević D (2018) Community-acquired Clostridium difficile infection in Serbian pediatric population. Eur J Clin Microbiol Infect Dis 37(6):1061–1069

    Article  Google Scholar 

  15. 15.

    Bidet P, Lalande V, Salauze B, Burghoffer B, Avesani V, Delmée M, Rossier A, Barbut F, Petit JC (2000) Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol 38(7):2484–2487

    CAS  Article  Google Scholar 

  16. 16.

    van Dorp SM, Smajlović E, Knetsch CW, Notermans DW, de Greeff SC, Kuijper EJ (2017) Clinical and microbiological characteristics of Clostridium difficile infection among hospitalized children in the Netherlands. Clin Infect Dis 64(2):192–198

    Article  Google Scholar 

  17. 17.

    Kuijper EJ, Coignard B, Tull P (2006) Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 12:2–18

    CAS  Article  Google Scholar 

  18. 18.

    Antonara S, Leber AL (2016) Diagnosis of Clostridium difficile infections in children. J Clin Microbiol 54(6):1425–1433

    CAS  Article  Google Scholar 

  19. 19.

    Schulze GE, Willoughby RE (2013) Committee on infectious diseases; American Academy of pediatrics. Clostridium difficile infection in infants and children. Pediatrics 131(1):196–200

    Article  Google Scholar 

  20. 20.

    Santiago B, Guerra L, Garcia-Morin M, Gonzalez E, Gonzalvez A, Martos A et al (2015) Clostridium difficile in children hospitalized with diarrhea. An Pediatr (Barc) 82(6):417–425

    CAS  Article  Google Scholar 

  21. 21.

    Ruuska T, Vesikari T (1990) Rotavirus disease in Finnish children: use of numerical scores for clinical clinical severity of diarrhoeal episodes. Scand J Infect Dis 22:259–267

    CAS  Article  Google Scholar 

  22. 22.

    Crobach MJ, Planche T, Eckert C, Barbut F, Terveer EM, Dekkers OM, Wilcox MH, Kuijper EJ (2016) European society of clinical microbiology and infectious diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect 22(Suppl 4):S63–S81

    Article  Google Scholar 

  23. 23.

    Benson L, Song X, Campos J, Singh N (2007) Changing epidemiology of Clostridium difficile-associated disease in children. Infect Control Hosp Epidemiol 28(11):1233–1235

    Article  Google Scholar 

  24. 24.

    Crews J, Anderson L, Waller K, Swartz M, DuPont H, Starke J (2015) Risk factors for community-associated Clostridium difficile asociated diarrhea in children. Pediatr Infect Dis J 34:919–923

    Article  Google Scholar 

  25. 25.

    Hong W, Cheng Y, Rao F, Yang J, Cui G, Chen Z et al (2018) Co-infection of Clostridioides (Clostridium) difficile GMU1 and Bacillus cereus GMU2 in one patient in Guizhou, China. Anaerobe 54:159–163

    Article  Google Scholar 

  26. 26.

    Stokely JN, Niendorf S, Taube S, Hoehne M, Young VB, Rogers MA et al (2016) Prevalence of human norovirus and Clostridium difficile co-infections in adult hospitalized patients. Clin Epidemiol 28(8):253–260

    Google Scholar 

  27. 27.

    de Graaf H, Pai S, Burns DA, Karas JA, Enoch DA, Faust SN (2015) Co-infection as a confounder for the role of Clostridium difficile infection in children with diarrhoea: a summary of the literature. Eur J Clin Microbiol Infect Dis 34(7):1281–1287

    Article  Google Scholar 

  28. 28.

    Kim J, Shaklee JF, Smathers S et al (2012) Risk factors and outcomes associated with severe Clostridium difficile infection in children. Pediatr Infect Dis J 31:134–138

    Article  Google Scholar 

  29. 29.

    Hojsak I, Ferenc T, Bojanić K, Mišak Z, Močić Pavić A, Lukić-Grlić A et al (2012) Incidence of Clostridium difficile infection in children with inflammatory bowel disease compared to oncology and immunocompetent patients. Digestion 86(1):6–11

    Article  Google Scholar 

  30. 30.

    Fisher BT, Sammons JS, Li Y, de Blank P, Seif AE, Huang YS et al (2014) Variation in risk of hospital-onset Clostridium difficile infection across β-lactam antibiotics in children with new-onset acute lymphoblastic leukemia. J Pediatric Infect Dis Soc 3(4):329–335

    Article  Google Scholar 

  31. 31.

    Kyne L, Warny M, Qamar A, Kelly CP (2001) Association between antibody response to toxin a and protection against recurrent Clostridium difficilediarrhoea. Lancet 20(357 (9251)):189–193

    Article  Google Scholar 

  32. 32.

    Adams DJ, Eberly MD, Rajnik M, Nylund CM (2017) Risk factors for community-associated Clostridium difficile infection in children. J Pediatr 186:105–109

    Article  Google Scholar 

  33. 33.

    Brow KA, Khanafer N, Danemen N, Fisman DN (2013) Meta –analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother 57:2326–2332

    Article  Google Scholar 

  34. 34.

    Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, LC MD, Society for Healthcare Epidemiology of America, Infectious Diseases Society of America et al (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31(5):431–455

    Article  Google Scholar 

  35. 35.

    Petrella LA, Sambol SP, Cheknis A, Nagaro K, Kean Y, Sears PS et al (2012) Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis 55(3):351–357

    CAS  Article  Google Scholar 

  36. 36.

    Marsh JW, Arora R, Schlackman JL, Shutt KA, Curry SR, Harrison LH (2012) Association of relapse of Clostridium difficile disease with BI/NAP1/027. J Clin Microbiol 50(12):4078–4082

    Article  Google Scholar 

  37. 37.

    Pichenot M, Héquette-Ruz R, Le Guern R, Grandbastien B, Charlet C, Wallet F et al (2017) Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University hospital. Infection 45(4):425–431

    CAS  Article  Google Scholar 

  38. 38.

    Centers for DiseaseControl and Prevention (CDC) (2005) Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005. MMWR Morb Mortal Wkly Rep 2(54(47)):1201–1205

    Google Scholar 

  39. 39.

    El Feghaly RE, Stauber JL, Deych E, Gonzalez C, Tarr PI, Haslam DB (2013) Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. Clin Infect Dis 56(12):1713–1721

    Article  Google Scholar 

  40. 40.

    Cobo J, Merino E, Martínez C, Cózar-Llistó A, Shaw E, Marrodán T, Calbo E, Bereciartúa E et al (2018) Nosocomial infection study group. Prediction of recurrent Clostridium difficile infection at the bedside: the GEIH-CDI score. Int J Antimicrob Agents 51(3):393–398

    CAS  Article  Google Scholar 

Download references

Acknowledgements

We thank mrs. Celine Harmanus, technician of the National Reference Laboratory Clostridium difficile Leiden University, The Netherlands, for assistance in designing of ribotyping Clostridium difficile isolates.

Funding

This study was funded by the Ministry of Education, Science and Technological Development of Serbia [Projects No. 172061].

Author information

Affiliations

Authors

Corresponding author

Correspondence to Stojanovic Predrag.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Was obtained from parents of all participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Predrag, S., Kuijper, E.J., Nikola, S. et al. Recurrent community-acquired Clostridium(Clostridioides)difficile infection in Serbianchildren. Eur J Clin Microbiol Infect Dis 39, 509–516 (2020). https://doi.org/10.1007/s10096-019-03751-4

Download citation

Keywords

  • Clostridium difficile
  • Recurrent CDI
  • Community acquired diarrhea
  • Children
  • Diarrhea